← Open Payments lookup

ADAM KAUL: Open Payments

NPI 1689653107 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,247 in 52 payments from 9 companies in 2025. Trend: 2023 $6,803 · 2024 $876 · 2025 $1,247

Food & beverage: $1,247
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.20$515
E.R. Squibb & Sons, L.L.C.9$262
Vanda Pharmaceuticals Inc.9$158
Otsuka America Pharmaceutical, Inc.3$75
Teva Pharmaceuticals USA, Inc.3$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Janssen Pharmaceuticals, Inc2$47
ABBVIE INC.2$43
Lundbeck LLC1$22

Products named: INGREZZA, COBENFY, FANAPT, CAPLYTA, HETLIOZ, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across VA — which companies pay providers there.